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I N T R O D U C T I O N
Neuropeptides, which form the largest and most structurally diverse group of signaling molecules, mediate an extensive array of central and peripheral effects in the nervous system of both vertebrates and invertebrates. Neuropeptide genes are often complex with multiple exons encoding diverse sets of neuropeptides (e.g., rat calcitonin gene) (Amara et al. 1982) . Alternative mRNA splicing may occur so that different tissues express different mRNA species originating from this same gene (Nawa et al. 1984) . The complexity of these patterns of expression and the colocalization of classical low molecular weight transmitters makes the study of multiple peptides in cell signaling difficult in the vertebrate system. The number of neurons is very large, and molecular and cellular analysis of neuropeptide function is difficult to study at the level of identified neurons. This is not the case in the pond snail, Lymnaea, where individual peptidergic neurons can be repeatedly identified for both molecular and electrophysiological analysis .
Recent studies of the FMRFamide gene of Lymnaea showed that it consists of five exons (Kellett et al. 1994 ) with FMRFamide and the related FLRFamide encoded exclusively on exon II (Linacre et al. 1990 ). This exon alone is expressed in a pair of heart motor neurons (Santama et al. 1995) whose excitatory actions on the myogenic heart can be mimicked by the application of FMRFamide (Buckett et al. 1990c) . FMRFamide is therefore a candidate transmitter for the excitatory actions of the heart motor neurons in the snail heart. Two further types of neuropeptides are also encoded on exon II of the Lymnaea FMRFamide gene (Linacre et al. 1990 ). One of these, the 22-amino acid peptide SEQPDVDDYLRDVVLQ-SEEPLY ("SEEPLY") was recently sequenced from the snail CNS and shown to be present in the FMRFamidergic heart motor neurons and the heart with a specific antibody (Santama et al. 1993) . It is therefore coexpressed with FMRFamide and may be a cotransmitter.
The objective of this investigation was to examine the function of SEEPLY on its presumed target organ, the heart, with a previously developed dissociated heart cell preparation (Brezden et al. 1986 ) that allowed patch-clamp techniques to be applied to single Lymnaea heart ventricle cells maintained in temporary cell culture. Specifically, the effect of SEEPLY on a previously characterized Ca 2ϩ channel was examined. This was shown to be a non-voltage-gated, second-messengermediated channel activated by the application of FMRFamide (Brezden et al. 1991 ). We will show that SEEPLY alone is unable to increase the P (open) time of the Ca 2ϩ channels but acts by modulating the ability of FMRFamide to open these channels. More specifically, SEEPLY can both up-and downregulate FMRFamide-activated Ca 2ϩ channel activity depending on the P (open) time of the channel in response to an initial application of FMRFamide.
M E T H O D S
The procedure for harvesting cells from Lymnaea heart ventricles and patch-clamp recording from the isolated cells were described in detail by Brezden et al. (1986) and Brezden and Gardner (1990) . Briefly, in a single dissociation, cells were harvested by digestion of a minimum of five heart ventricles for 30 min in 0.25% trypsin (SIGMA type XII-S) and subsequently for 2 h in 0.1% collagenase (SIGMA, type II-S) in modified Leibovitz's (L-15) medium containing 0.5 mM Ca 2ϩ . The harvested cells were then divided into four equal aliquots, and each aliquot was plated onto a glass coverslip placed in the bottom of a 35-mm plastic petri dish and incubated at room temperature (20 -25°C) in modified L-15 medium containing 3.5 mM Ca 2ϩ . The modified L-15 medium was prepared by diluting 7 parts of L-15 (stock prepared from powder, Gibco) with 18 parts of saline stock. The salt concentration of the saline stocks was adjusted to provide on dilution with the L-15 stock 59.0 mM Na ϩ (dissociation) or 50.0 mM Na ϩ (incubation), 0.5 mM Ca 2ϩ (dissociation) or 3.5 mM Ca 2ϩ (incubation), 1.75 mM K ϩ , 2.0 mM Mg 2ϩ , 10.0 mM HEPES buffer (pH 7.7-7.8), 0.1 mg/ml gentamycin (Gibco), and 32 mM glucose. In addition, the incubation medium contained 2% vol/vol fetal calf serum (Gibco). For patch-clamp recording the coverslips were transferred to normal saline containing (in mM) 50.0 NaCl, 3.5 CaCl 2 , 1.6 KCl, 2.0 MgCl 2 , and 10.0 HEPES buffer (pH 7.7-7.8).
Patch pipettes were pulled from thick-walled Corning 7052 (Kovar) glass (1.65 mm OD, 0.8 mm ID) to give tip openings of 1-to 1.5-m diam. The tips of the patch pipettes were fire polished and coated with Sylgard 184 elastomer (Dow-Corning). Channel currents were amplified with a List EPC-7 patch clamp (Medical Systems) and recorded on videotape with an Instrutech VR-10 digital recorder for subsequent analysis with pClamp software (Axon Instruments). For dwell-time measurements the data were filtered at 2-4 kHz with a four-pole Bessel filter. The channel detection threshold was set midway between the baseline and the open channel level.
The Ca 2ϩ currents in Lymnaea heart ventricle cells are very small and difficult to detect. To amplify the current flux through the Ca 2ϩ channels, 60.5 mM NaCl and 1 mM EGTA was used in the patch pipettes. It was established that with the removal of external Ca 2ϩ Na ϩ substitutes for Ca 2ϩ as the permeant ion through the Ca 2ϩ channels in these cells (Brezden and Gardner 1990; Brezden et al. 1991) . Consequently, although the channels are referred to as Ca 2ϩ channels, it should be emphasized that the currents through these channels were in fact carried by Na ϩ ions. At least two different non-voltage-gated Ca 2ϩ channels were previously recorded in dissociated heart ventricle cells (Brezden and Gardner 1990; Brezden et al. 1991) . They were separated according to their single channel conductance into large conductance (LG) and small conductance (SG) channels. The data presented in this paper are from recordings of LG. These channels have previously been shown to have at least two subconductance states with channel openings consisting of a mixture of flickery and longer-duration openings (Brezden et al. 1991) . Thus the apparent mixture of unitary currents depicted in Fig. 3 does in fact represent different modes of a single channel. Data were analyzed from recordings with a single LG channel in the pipette.
Synthetic FMRFamide was obtained from Sigma Chemical. SEEPLY was synthesized and purified by Alta Bioscience (Dept. of Biochemistry, University of Birmingham, UK). The peptides were applied to an area away from the patch pipette by means of separate glass superfusion pipettes with the tips positioned at distances ranging from 20 to 50 m from the cell. The pipette openings were ϳ1.5 m in diameter. The pipette contents were ejected with a gas-driven automatic syringe pump that was controlled by a timing circuit. An electronic valve system allowed ejection of the contents from either of the two pipettes or both simultaneously. Marker dye studies showed that the superfusate traveled a distance of ϳ100 m in ϳ0.5 s with the application of 3 lb. pressure.
Early experiments were performed with 10 Ϫ7 to 10 Ϫ6 M SEEPLY and 10 Ϫ7 M FMRFamide. However, the results were more consistent when the SEEPLY concentration was increased to 10 Ϫ5 M. Although the results were qualitatively similar at all SEEPLY concentrations, the data that were analyzed quantitatively and are presented in this paper used 10 Ϫ5 M SEEPLY.
Data presentation
All data were obtained from cell-attached patches. Most of the experimental data are presented as scatter plots that were derived from single sweeps of the channel activity traces. Each scatter plot represents the activity of a single channel. In these plots the duration of each individual channel opening is plotted along a time axis, designating the point in time at which the event occurred. This format provides a clear visual presentation of changes in the levels of channel activity with time and during different treatments. Note, however, that the compression of the timescale in the scatter plots may create the appearance that some events occurred simultaneously. Events that appear to be vertically aligned were in fact separated by time intervals that were too short to be clearly resolved in these scatter plots.
Quantitative results of the population data were obtained by calculating the probability of the channel being open (P (open) ) for the duration of the treatment (usually 120 s), thus forming a mean P (open) value for each treatment.
Statistical analysis of data
Cells for each experiment described in RESULTS were obtained from at least four different dissections with each dissociation being the result of enzyme treatment of at least five different hearts. Cells from each separate dissociation were divided equally among four separate 35-mm petri dishes. Although data for a particular experiment were obtained from recordings of a large number of different cells, those cells were obtained from relatively few dissociations (minimum of 4 per experiment). Although we saw no gross changes in the behavior of cells from one dissociation to the next, there existed the possibility that cells recorded from a "poor" dissociation could significantly influence the population data yielding misleading results. To nullify this possible source of error, levels of significance were determined by using the number of dissociations as the N number for determining the degrees of freedom. P (open) times from cells from each dissociation were initially averaged to obtain a mean P (open) time for each dissociation. Values from different dissociations were then averaged to yield a mean P (open) value for the experiment. Significant differences among treatments were determined by using t-tests.
R E S U L T S

SEEPLY alone does not affect Ca 2ϩ channel activity
The application of 10 Ϫ7 to 10 Ϫ5 M SEEPLY alone to cells that were not previously exposed to FMRFamide or SEEPLY (naive cells) did not have any significant effect on Ca 2ϩ channel activity (28 cells). In five of these experiments where patches were subsequently challenged with FMRFamide, occasional spontaneous openings could be recorded (P (open) 0.00008 Ϯ 0.0008; means Ϯ SE) but these were not affected by the application of SEEPLY (P (open) SEEPLY 0.0002 Ϯ 0.0003; P Ͼ 0.05; n ϭ 4; see Fig. 1B ). However, FMRFamide did promote a significant increase in LG Ca 2ϩ channel activity in those patches where SEEPLY had previously been shown to have no affect (P (open) 0.0985 Ϯ 0.011; n ϭ 4) ( Fig. 1, A and B) . Previous experiments demonstrated that the application of 10 Ϫ7 M FMRFamide to naive heart ventricle cells is capable of activating the same type of Ca 2ϩ channel (LG) (Brezden et al. 1991) . Taken together these data indicate that naive cells were capable of responding to FMRFamide but not to SEEPLY with increased Ca 2ϩ channel activity (see also Brezden et al. 1991) .
Ca 2ϩ channel activity is lost after successive applications of FMRFamide
Although LG Ca 2ϩ channels could be activated by FMRFamide, the response to this peptide was invariably lost after several successive applications (Brezden et al. 1991) . Figure 2 shows the response of an isolated heart cell to five successive 15-s applications of 10 Ϫ7 M FMRFamide (30 cells). The first and second applications were associated with a relatively large increase in Ca 2ϩ channel activity. However, the FMRFamideinduced activity was greatly reduced by the third application, and the cell became essentially nonresponsive to the fifth application. Washing the cells between applications did not prevent this loss of response nor could the response be restored by washing the cells for Յ1 h with normal saline.
We have therefore shown that FMRFamide can regulate LG Ca 2ϩ channel activity over two distinct timescales. Over a relatively fast timescale FMRFamide increases the P (open) time of the these channels. However, on repeated applications FMRFamide loses this ability, suggesting that over a relatively slow timescale its main effect is to decrease the P (open) time of these channels.
In the following sections we will show that the effects of SEEPLY on FMRFamide-activated Ca 2ϩ channel activity also occurs over two distinct timescales.
SEEPLY prevents the of loss of response to repeated applications of FMRFamide
Whereas SEEPLY alone did not activate LG Ca 2ϩ channel activity, it did prevent the loss of response of these Ca 2ϩ channels to FMRFamide (12 cells; n ϭ 5). The experimental data traces presented in Fig. 3 show that the response to FMRFamide was maintained if the cell was also exposed to SEEPLY. This cell was exposed to five 240-s application cycles consisting of a 120-s application of 10 Ϫ7 M FMRFamide followed by a 120-s application of 10 Ϫ5 M SEEPLY ϩ 10 Ϫ7 M FMRFamide for a total exposure time to FMRFamide of 20 min. Only the fifth (last) exposure cycle is shown. The channel activity at ϳ41 s into the fifth application of FMRFamide is shown in Fig. 3A . After ϳ90 s of exposure the activity subsided considerably (Fig. 3B ) before the application of FMRFamide ϩ SEEPLY at 120 s. The trace in Fig. 3C shows the increased level of activity ϳ20 s after the exposure to SEEPLY ϩ FMRFamide. The response to FMRFamide persisted even up to 20 min of continuous exposure, in contrast to the rapid loss of response observed in the absence of SEEPLY (cf. Fig. 2 ). In Fig. 4 ; n ϭ 7) and FMRFamide ϩ SEEPLY (P (open) 0.024 Ϯ 0.003; n ϭ 5). Statistical analysis of these data showed that channel activity after the fifth application of FMRFamide ϩ SEEPLY was significantly greater than that seen after the fifth application of FMRFamide alone (P Ͻ 0.05). Although a statistical comparison of the data was only performed after the fifth application of the peptides, SEEPLY-treated cells were seen to respond to FMRFamide for as long as the patch was viable, which was Յ1 h.
It is important to note that, although the coapplication of SEEPLY and FMRFamide can prevent the loss of Ca 2ϩ channel activity seen when FMRFamide is repeatedly applied alone, once FMRFamide induced a loss of response it cannot be recovered by the subsequent application of SEEPLY (data not shown).
The ability of SEEPLY to prevent the loss of response of the LG Ca 2ϩ channel to repeated applications of FMRFamide is suggestive that its actions occur over a realtively slow timescale. However, SEEPLY like FMRFamide was also capable of either up-or down-regulating FMRFamide-activated Ca 2ϩ channel activity over a relatively fast timescale. 
SEEPLY can up-regulate the FMRFamide response
The presence of an LG Ca 2ϩ channel in a patch could be recognized by unitary inward currents that appeared on the formation of a gigaseal. These inward currents usually disappeared shortly after seal formation but could be reactivated by superfusing the cell with FMRFamide (Brezden et al. 1991 ). FMRFamide-induced activity was often characterized by bursts of channel activity (e.g., see Figs. 1 and 5) . However, the first application of FMRFamide to different naive cells produced markedly different degrees of Ca 2ϩ channel activity. Sometimes the FMRFamide-evoked activity was relatively low. When the P (open) value of FMRFamide-induced activity was 0.004 Ϯ 0.002 (13 cells; n ϭ 4) the application of SEEPLY during FMRFamide treatment promoted an increase in Ca 2ϩ channel activity. Figure 5 shows the data from an experiment where the response to FMRFamide was initially weak. The subsequent application of 10 Ϫ5 M SEEPLY during FMRFamide exposure significantly increased the Ca 2ϩ channel activity (P Ͻ 0.05).
As is evident from the scatter plots, in the absence of FMRFamide Ca 2ϩ channel open dwell times were generally very brief (e.g., see Fig. 1 ). The application of FMRFamide or FMRFamide ϩ SEEPLY not only increased the frequency of the channel openings but also appeared to increase the open dwell time. However, the low frequency of the channel openings in naive cells in these experiments made it impossible to examine this observation statistically. In earlier investigations, where this question was addressed directly, it was shown that the open channel dwell-time kinetics were identical for spontaneous and FMRFamide-activated channels with Na ϩ as the FIG. 2. Ability of FMRFamide to activate Ca 2ϩ channels in isolated heart cells is reduced and eventually lost with successive applications of this peptide. The heavy horizontal bars mark the time and duration of application of 10 Ϫ7 M FMRFamide (5 separate15-s applications). The first application of FMRFamide promoted a large increase in Ca 2ϩ channel activity. However, the response to FMRFamide was reduced during subsequent applications and was virtually abolished by the last application. There was no intervening wash between FMRFamide applications in this experiment. charge carrier (Brezden and Gardner 1990; Brezden et al. 1991) .
The Ca 2ϩ channel density in isolated Lymnaea heart cells appeared to be relatively low as usually only a single channel was present in a patch, and no inward channel currents could be detected in ϳ20% of the cells. In the absence of any background spontaneous activity it was assumed that no Ca 2ϩ channels were present. However, in two cells where a single 300-s application of FMRFamide alone initially failed to activate Ca 2ϩ channels, the subsequent application of SEEPLY conferred a response to FMRFamide (Fig. 6) , suggesting that Ca 2ϩ channels were present in these patches but the channels were not initially responsive to FMRFamide. Therefore although SEEPLY alone had no effect on Ca 2ϩ channel activity it was able to induce FMRFamide sensitivity to previously nonresponsive channels. The small number of cells in which this phenomenon was observed prevented any detailed statistical analysis.
SEEPLY can down-regulate the FMRFamide response
Our evidence suggests that SEEPLY can also down-regulate, or reduce, the level of FMRFamide-activated LG Ca 2ϩ channel activity. When the P (open) value of FMRFamide-induced activity was "high" (mean ϭ 0.058 Ϯ 0.017; 8 cells; n ϭ 4) the application of SEEPLY during FMRFamide treatment resulted in a reduction of the frequency of channel openings. An example of this type of result is shown in Fig. 7 where the application of 10 Ϫ5 M SEEPLY during FMRFamide exposure significantly reduced FMRFamide-induced Ca 2ϩ channel activity (P Ͻ 0.05). There also appeared to be a reduction in the open dwell time of the channel, but as in the previous example there were not enough data to perform a statistical analysis.
SEEPLY can up-and down-regulate the FMRFamide response in the same cell
Up-and down-regulation of the FMRFamide response by SEEPLY was often seen in the same cell. In the experiment shown in Fig. 8 
and 4) within the lifetime of the patches (Յ1 h).
The results of experiments with 32 applications of SEEPLY and SEEPLY ϩ FMRFamide to 13 different cells (from 4 dissociations; a minimum of 20 different hearts) are summarized in Fig. 9 . The first important observation is that the application of FMRFamide allowed us to distinguish two populations of cells whose mean P (open) times are significantly different from one another (P Ͻ 0.05). In the case of cells that showed up-regulation (20 episodes) the mean Ca 2ϩ channel P (open) during FMRFamide treatment was 0.004 Ϯ 0.002. The coapplication of FMRFamide and SEEPLY significantly increased the P (open) to 0.027 Ϯ 0.011 (P Ͻ 0.05). Where down-regulation was observed (12 episodes) the mean P (open) was 0.058 Ϯ 0.017 during FMRFamide treatment, which was significantly decreased to 0.013 Ϯ 0.004 by superfusion with a combination of FMRFamide and SEEPLY (P Ͻ 0.05). It should be noted that there is no significant difference between the P (open) values of the two FMRFamide ϩ SEEPLY data sets, indicating that SEEPLY functions to maintain FMRFamideactivated Ca 2ϩ channel activity at some defined level. SEEPLY's ability to cause both up-and down-regulation of FMRFamide-gated channel activity is extremely unusual, and so it was important to have unequivocal validation of the data. Because there were fewer examples of down-regulation there existed the possibility, although remote, that these episodes were the result of either a single "poor" dissociation or a difference in the properties of cells in different petri dishes. To eliminate batch variability as a factor we performed a further statistical analysis on the data. This involved randomly assigning the data from each cell to one of four groups rather than assigning them to groups based on the dissociation they came from. As described previously, both FMRFamide-treated groups were significantly different from one another (P Ͻ 0.05), indicating that we were dealing with two distinct populations of cells. In cells that showed up-regulation P (open) times were increased from 4.39 ϫ 10 Ϫ3 Ϯ 7.98 ϫ 10 Ϫ4 to 2.67 ϫ 10 Ϫ2 Ϯ 6.45 ϫ 10 Ϫ3 (P Ͻ 0.05), whereas cells in which down-regulation was observed showed a decrease in the mean P (open) time from 5.78 ϫ 10 Ϫ2 Ϯ 1.4 ϫ 10 Ϫ2 to 1.25 ϫ 10 Ϫ2 Ϯ 2.74 ϫ 10 Ϫ3 (P Ͻ 0.05). By using this second type of analysis, there was still no significant difference between the two FMRFamide ϩ SEEPLY data sets, indicating that up-and down-regulation of channel activity was to a common range of values. This more rigorous analysis clearly demonstrates that SEEPLY's effects on FMRFamide-gated channel activity were not due to problems with particular batches of cells.
D I S C U S S I O N
SEEPLY modulates FMRFamide-action in Lymnaea heart muscle cells
Our observation that FMRFamide can over a fast timescale increase the P (open) time of the LG Ca 2ϩ channel provides confirmation of previous work by Brezden et al. (1991) . The application of SEEPLY alone to isolated heart muscle cells had no effect on LG Ca 2ϩ channel activity. However, when SEEPLY was applied together with FMRFamide to isolated heart muscle cells, FMRFamide-induced Ca 2ϩ channel activity was either increased or decreased, depending on the level of FMRFamideinduced activity present immediately before the coapplication of the two peptides. In only 1 of 32 applications was the channel activity not significantly changed. To quantify these results with the probability of the channel being open as an indicator of activity, it was found that when P (open) was Ͻ0.004 Ϯ 0.002, SEEPLY ϩ FMRFamide increased the Ca 2ϩ channel activity, whereas if P (open) was Ͼ0.058 Ϯ 0.017 the application of SEEPLY ϩ FMRFamide decreased the FMRFamide-induced activity. It is unlikely that down-regulation was the result of competition between SEEPLY and FMRFamide for the same receptor or of dilution of the FMRFamide by SEEPLY because both up- and down-regulation were observed in the same cell. Both up-and down-regulation are examples of the actions of SEEPLY that occur over a relatively fast timescale.
Over a fast timescale FMRFamide was capable of increasing the P (open) time of the LG Ca 2ϩ channel; however, repetitive applications of FMRFamide demonstrated that over a slower timescale its main effect was to decrease channel activity and eventually cause a complete loss of response. This led to the possibility that the down-regulation of channel activity that we saw in response to application of SEEPLY (Figs. 7 and 8, 2nd SEEPLY application) might in fact be due to these slower effects of FMRFamide. However, this is unlikely to be the case as the coapplication of SEEPLY and FMRFamide prevented any loss of FMRFamide-induced channel activity. The ability of SEEPLY to prevent a loss of response occurred over a relatively slow timescale and was distinct from its faster effects (up-and downregulation) . It was interesting to note that, although SEEPLY was unable to reverse the loss of response seen after repeated applications of FMRFamide, it was capable of inducing FMRFamide sensitivity to two cells that were initially unresponsive after a single application of FMRFamide. The prevention of the loss of the FMRFamide response by SEEPLY and the ability of SEEPLY to confer FMRFamide sensitivity to previously nonresponsive cells can be considered as further examples of up-regulation. The mechanism underlying the initial lack or subsequent loss of response to FMRFamide is not known but is unlikely to involve a common mechanism as SEEPLY is unable to reverse the loss of response seen after repeated applications of FMRFamide.
The ability of SEEPLY to both up-and down regulate FMRFamide-activated LG channel activity suggests that there may be a physiological "set-point" value for P (open) . This implies that a mechanism with the properties of a negative feedback system is operating to achieve a specific value of P (open) for the Ca 2ϩ channel. A more accurate way of describing these results would be to consider that a range of P (open) values is achieved by the feedback mechanism rather than a specific set point or single value. We assume that normally FMRFamide and SEEPLY would be released together to allow the proposed control system to operate, and we recently obtained evidence in our laboratory to show the Ca 2ϩ -dependant corelease of both peptides from the heart (A. C. Dobbins, unpublished data).
The nature of this feedback mechanism is not known, and it is postulated here solely as a working hypothesis. Up-and down-regulation of the activity of a nonspecific cationic channel was previously described by Wilson and Kaczmarek (1993) . By using excised inside-out patches from the bag cell neurons of Aplysia the authors demonstrated that application of the catalytic subunit of protein kinase A (PKA) was capable of either up-or down-regulating channel activity, depending on the initial activity of the channel. The authors referred to the change in activity as "mode switching" as application of PKA either changed channel activity from a bursting (low P (open) ) mode to a high activity (high P (open) ) mode or converted a channel in high-activity mode to one with bursting kinetics and a correspondingly lower P (open) . The initial activity state of the channel was shown to be a consequence of tyrosine phosphorylation, with phosphorylated channels exhibiting bursting kinetics and unphosphorylated channels being tonically active. Mode switching was regulated by the actions of a PKAregulated tyrosine phosphatase. In the absence of sufficient data it is impossible to determine whether SEEPLY is inducing mode switching of the sort described Wilson and Kaczmarek (1993) , although previous work by Brezden et al. (1991) suggests this is unlikely. However, our observation that the LG Ca 2ϩ channel appears to be regulated in a similar way is suggestive that this may be a common means of regulating channel activity.
Previous work on molluscan muscle has shown that modulation either involves different neuropeptides affecting different channel types or the same channel to different degrees (Brezina et al. 1994a,b) or acting at the presynaptic site to regulate transmitter release (Cropper et al. 1988 (Cropper et al. , 1990 . As is the case for FMRFamide, the action of SEEPLY is also likely to be mediated by a second messenger as modulation of the FMRFamide response is evident when SEEPLY is applied outside the patch pipette. In neither case are the messenger systems associated with either FMRFamide or SEEPLY known. However, the complex interactions of the two peptides and their different roles, SEEPLY modulating the ability of FMRFamide to open Ca 2ϩ channels, may mean that different second-messenger systems are involved.
Comparison with other systems
FMRFamide activates sarcolemmal Ca 2ϩ channels in isolated Lymnaea heart cells, and application of FMRFamide often causes contraction in the same cells (Brezden et al. 1991) . Application of FMRFamide to the whole heart increases the rate of myogenic heart beat as well as the underlying tonus (Buckett et al. 1990a) . Although the effects of FMRFamide are likely to be complex, it is reasonable, on the basis of comparison with other muscle systems, that the increased influx of Ca 2ϩ would be associated with an increase in the strength of contraction either by direct association of externally derived Ca 2ϩ with the contractile apparatus or by Ca 2ϩ -activated release of Ca 2ϩ from intracellular stores. Invertebrate smooth and cardiac muscle contraction is blocked by dihydropyridines and other Ca 2ϩ channel blockers, and entry of extracellular Ca 2ϩ is equally important in a variety of molluscan muscles that were examined (e.g., Hill et al. 1970; Ram et al. 1984) . This suggests that the entry of extracellular Ca 2ϩ is required for contraction of molluscan muscles.
In Lymnaea, FMRFamide is thought to be acting as the major transmitter for a pair of excitatory heart motor neurons called the E he cells (Buckett et al. 1990c ). Immunocytochemical, radioimmunological (Buckett et al. 1990a,c) , and molecular analysis (Santama et al. 1995) showed that FMRFamide is present in the cell body of the E he cells and nerve terminals in the heart. Large quantities of FMRFamide are present in the heart (mean concentration of 31.8 pmol/mg wet weight of tissue) (Buckett et al. 1990a ). Application of FMRFamide to the heart closely mimics the effect of neuronal stimulation so that both can initiate beating in a quiescent heart or modulate beat rate and tonus in a similar manner. In this system FMRFamide is considered to act as a primary transmitter and is therefore behaving in a similar fashion to vasoactive intestinal peptide (Wakade et al. 1991) in vertebrates. This is unlike the invertebrate muscle systems that were studied such as the buccal musculature of Aplysia where ACh is the primary transmitter in several types of motor neurons (Cohen et al. 1978) . In the Aplysia accessory radula closer (ARC) system, ACh causes contraction by depolarizing the muscle and causing Ca 2ϩ influx (Brezina and Weiss 1993; Ram and Parti 1985) , but in Lymnaea FMRFamide a peptidergic rather than a classical, low molecular weight transmitter causes Ca 2ϩ influx by activating a membrane Ca 2ϩ channel. In the Lymnaea heart ACh inhibits the heartbeat and is the transmitter of a completely different motor neuron type (Buckett et al. 1990b) .
As well as primary transmitters such as ACh (Cohen et al. 1978) and glutamate (Bishop et al. 1991) , invertebrate motor neurons also contain neuropeptides that act as ion channel modulators. In crayfish proctolin is colocalized with glutamate (Bishop et al. 1984 (Bishop et al. , 1987 in three excitatory motor neurons innervating the muscle of the animal's abdomen. Proctolin does not itself induce tension in the muscle but acts directly on the muscle to amplify the effect of glutamate. Only when glutamate first depolarizes the muscle membrane does proctolin modulate muscle contraction. Bishop et al. (1991) showed that proctolin is able to act on Ca 2ϩ channels, which are first activated by depolarization, to prolong their period of activity. This probably plays an important role in the potentiation of tension in the crayfish muscle. In some ways this action of proctolin resembles that of SEEPLY in Lymnaea heart muscle cells. SEEPLY alone cannot open Ca 2ϩ channels but when combined with FMRFamide influences the activity of the Ca 2ϩ channels. However, unlike proctolin, SEEPLY appears to be able to up-or down-regulate Ca 2ϩ channel activity, depending on the initial response to FMRFamide. This is seen as part of a negative feedback system to maintain a particular level of Ca 2ϩ channel activity, whereas in the case of proctolin the muscle response is always potentiated and prolonged by the action of the modulator. Similar enhancement of a Ca 2ϩ current was recently reported in the ARC muscle of Aplysia by Brezina et al. (1994a) . The modulator myomodulin increases the size of a voltage-gated Ca 2ϩ current in the muscle and modulates the contraction of the muscle evoked by the primary transmitter ACh. The complexity of the system is increased by the fact that myomodulin can also activate a K ϩ current in the same muscle cells (Brezina et al. 1994b) . The possibility that FMRFamide may also influence more than one channel type in Lymnaea heart muscle was not yet examined but could account for the complexity of the FMRFamide effect on the whole heart (increase in tonus, beat rate, and ability to initiate beating).
